Industry: Medical Devices & Consumables
Published Date: 2026-03-31
Pages: 92 Pages
Report ld: 6391616
Request Sample
Customized Report
Muscle-on-a-Chip Market Size(US$)

CAGR 2026-2032
26.1%
Market Size,2032
USD 1,784
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
As an emerging market segment in the biomedical field, the muscle chip market has gradually attracted widespread attention from the industry in recent years. Muscle chips can simulate the structure and function of muscle tissue, providing a powerful tool for the research of muscle-related diseases, drug development and personalized medicine. Muscle chips have broad application potential in multiple fields, including diagnosis of muscle diseases, drug screening, toxicity testing, sports rehabilitation, and personalized medicine. By simulating the physiological and pathological processes of muscle tissue, muscle chips can help researchers gain a deeper understanding of the pathogenesis of muscle diseases, accelerate drug development, and improve treatment effects. Overall, the muscle chip market has broad development prospects and huge market potential.
The global Muscle-on-a-Chip market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Muscle-on-a-Chip sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Muscle-on-a-Chip manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Muscle-on-a-Chip product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Muscle-on-a-Chip value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Muscle-on-a-Chip Product Scope
1.2 Muscle-on-a-Chip by Type
1.2.1 Global Muscle-on-a-Chip Sales by Type (2021, 2025 & 2032)
1.2.2 Skeletal Muscle
1.2.3 Smooth Muscle
1.2.4 Other
1.3 Muscle-on-a-Chip by Application
1.3.1 Global Muscle-on-a-Chip Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Pharmaceutical R&D
1.3.3 Sports Medicine
1.3.4 Sports Equipment Development
1.4 Global Muscle-on-a-Chip Market Estimates and Forecasts (2021-2032)
1.4.1 Global Muscle-on-a-Chip Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Muscle-on-a-Chip Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Muscle-on-a-Chip Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Muscle-on-a-Chip Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Muscle-on-a-Chip Historical Market Scenario by Region (2021-2026)
2.2.1 Global Muscle-on-a-Chip Sales Market Share by Region (2021-2026)
2.2.2 Global Muscle-on-a-Chip Revenue Market Share by Region (2021-2026)
2.3 Global Muscle-on-a-Chip Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Muscle-on-a-Chip Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Muscle-on-a-Chip Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Muscle-on-a-Chip Market Size and Prospects (2021-2032)
2.4.2 Europe Muscle-on-a-Chip Market Size and Prospects (2021-2032)
2.4.3 China Muscle-on-a-Chip Market Size and Prospects (2021-2032)
2.4.4 Japan Muscle-on-a-Chip Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Muscle-on-a-Chip Historical Market Review by Type (2021-2026)
3.1.1 Global Muscle-on-a-Chip Sales by Type (2021-2026)
3.1.2 Global Muscle-on-a-Chip Revenue by Type (2021-2026)
3.1.3 Global Muscle-on-a-Chip Average Price by Type (2021-2026)
3.2 Global Muscle-on-a-Chip Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Muscle-on-a-Chip Sales Forecast by Type (2027-2032)
3.2.2 Global Muscle-on-a-Chip Revenue Forecast by Type (2027-2032)
3.2.3 Global Muscle-on-a-Chip Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Muscle-on-a-Chip
4 Global Market Size by Application
4.1 Global Muscle-on-a-Chip Historical Market Review by Application (2021-2026)
4.1.1 Global Muscle-on-a-Chip Sales by Application (2021-2026)
4.1.2 Global Muscle-on-a-Chip Revenue by Application (2021-2026)
4.1.3 Global Muscle-on-a-Chip Average Price by Application (2021-2026)
4.2 Global Muscle-on-a-Chip Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Muscle-on-a-Chip Sales Forecast by Application (2027-2032)
4.2.2 Global Muscle-on-a-Chip Revenue Forecast by Application (2027-2032)
4.2.3 Global Muscle-on-a-Chip Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Muscle-on-a-Chip Applications
5 Competition Landscape by Players
5.1 Global Muscle-on-a-Chip Sales by Player (2021-2026)
5.2 Global Top Muscle-on-a-Chip Players by Revenue (2021-2026)
5.3 Global Muscle-on-a-Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Muscle-on-a-Chip revenue as of 2025
5.4 Global Muscle-on-a-Chip Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Muscle-on-a-Chip, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Muscle-on-a-Chip, Product Type & Application
5.7 Global Key Manufacturers of Muscle-on-a-Chip, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Muscle-on-a-Chip Sales by Company
6.1.1.1 North America Muscle-on-a-Chip Sales by Company (2021-2026)
6.1.1.2 North America Muscle-on-a-Chip Revenue by Company (2021-2026)
6.1.2 North America Muscle-on-a-Chip Sales Breakdown by Type (2021-2026)
6.1.3 North America Muscle-on-a-Chip Sales Breakdown by Application (2021-2026)
6.1.4 North America Muscle-on-a-Chip Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Muscle-on-a-Chip Sales by Company
6.2.1.1 Europe Muscle-on-a-Chip Sales by Company (2021-2026)
6.2.1.2 Europe Muscle-on-a-Chip Revenue by Company (2021-2026)
6.2.2 Europe Muscle-on-a-Chip Sales Breakdown by Type (2021-2026)
6.2.3 Europe Muscle-on-a-Chip Sales Breakdown by Application (2021-2026)
6.2.4 Europe Muscle-on-a-Chip Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Muscle-on-a-Chip Sales by Company
6.3.1.1 China Muscle-on-a-Chip Sales by Company (2021-2026)
6.3.1.2 China Muscle-on-a-Chip Revenue by Company (2021-2026)
6.3.2 China Muscle-on-a-Chip Sales Breakdown by Type (2021-2026)
6.3.3 China Muscle-on-a-Chip Sales Breakdown by Application (2021-2026)
6.3.4 China Muscle-on-a-Chip Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Muscle-on-a-Chip Sales by Company
6.4.1.1 Japan Muscle-on-a-Chip Sales by Company (2021-2026)
6.4.1.2 Japan Muscle-on-a-Chip Revenue by Company (2021-2026)
6.4.2 Japan Muscle-on-a-Chip Sales Breakdown by Type (2021-2026)
6.4.3 Japan Muscle-on-a-Chip Sales Breakdown by Application (2021-2026)
6.4.4 Japan Muscle-on-a-Chip Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Emulate
7.1.1 Emulate Company Information
7.1.2 Emulate Business Overview
7.1.3 Emulate Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Emulate Muscle-on-a-Chip Products Offered
7.1.5 Emulate Recent Development
7.2 CN Bio
7.2.1 CN Bio Company Information
7.2.2 CN Bio Business Overview
7.2.3 CN Bio Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.2.4 CN Bio Muscle-on-a-Chip Products Offered
7.2.5 CN Bio Recent Development
7.3 TissUse
7.3.1 TissUse Company Information
7.3.2 TissUse Business Overview
7.3.3 TissUse Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.3.4 TissUse Muscle-on-a-Chip Products Offered
7.3.5 TissUse Recent Development
7.4 Axion Biosystems
7.4.1 Axion Biosystems Company Information
7.4.2 Axion Biosystems Business Overview
7.4.3 Axion Biosystems Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Axion Biosystems Muscle-on-a-Chip Products Offered
7.4.5 Axion Biosystems Recent Development
7.5 Nortis
7.5.1 Nortis Company Information
7.5.2 Nortis Business Overview
7.5.3 Nortis Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Nortis Muscle-on-a-Chip Products Offered
7.5.5 Nortis Recent Development
7.6 BioIVT
7.6.1 BioIVT Company Information
7.6.2 BioIVT Business Overview
7.6.3 BioIVT Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.6.4 BioIVT Muscle-on-a-Chip Products Offered
7.6.5 BioIVT Recent Development
7.7 InSphero
7.7.1 InSphero Company Information
7.7.2 InSphero Business Overview
7.7.3 InSphero Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.7.4 InSphero Muscle-on-a-Chip Products Offered
7.7.5 InSphero Recent Development
7.8 Mimetas
7.8.1 Mimetas Company Information
7.8.2 Mimetas Business Overview
7.8.3 Mimetas Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Mimetas Muscle-on-a-Chip Products Offered
7.8.5 Mimetas Recent Development
7.9 Ascendance Biotechnology
7.9.1 Ascendance Biotechnology Company Information
7.9.2 Ascendance Biotechnology Business Overview
7.9.3 Ascendance Biotechnology Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Ascendance Biotechnology Muscle-on-a-Chip Products Offered
7.9.5 Ascendance Biotechnology Recent Development
7.10 StemoniX
7.10.1 StemoniX Company Information
7.10.2 StemoniX Business Overview
7.10.3 StemoniX Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.10.4 StemoniX Muscle-on-a-Chip Products Offered
7.10.5 StemoniX Recent Development
7.11 Tara Biosystems
7.11.1 Tara Biosystems Company Information
7.11.2 Tara Biosystems Business Overview
7.11.3 Tara Biosystems Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Tara Biosystems Muscle-on-a-Chip Products Offered
7.11.5 Tara Biosystems Recent Development
7.12 BGI Genomics
7.12.1 BGI Genomics Company Information
7.12.2 BGI Genomics Business Overview
7.12.3 BGI Genomics Muscle-on-a-Chip Sales, Revenue and Gross Margin (2021-2026)
7.12.4 BGI Genomics Muscle-on-a-Chip Products Offered
7.12.5 BGI Genomics Recent Development
8 Muscle-on-a-Chip Manufacturing Cost Analysis
8.1 Muscle-on-a-Chip Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Muscle-on-a-Chip
8.4 Muscle-on-a-Chip Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Muscle-on-a-Chip Distributors List
9.3 Muscle-on-a-Chip Customers
10 Muscle-on-a-Chip Market Dynamics
10.1 Muscle-on-a-Chip Industry Trends
10.2 Muscle-on-a-Chip Market Drivers
10.3 Muscle-on-a-Chip Market Challenges
10.4 Muscle-on-a-Chip Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 167
USD 4900.00
(Single User License)
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 112
USD 3950.00
(Single User License)
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-15
Pages: 124
USD 2900.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 97
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 113
USD 3950.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 122
USD 4350.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 167
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 112
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-15
Pages: 124
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published: 2025-03-10
Pages: 94
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 97
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 113
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now